BIM
GILD icon

Bridgecreek Investment Management’s Gilead Sciences GILD Stock Holding History

Bridgecreek Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-66,855
Closed -$4.79M – 109
2016
Q4 		$4.79M Buy
66,855
+4,980
+8% +$370K 1.35% 39
2016
Q3 		$4.9M Sell
61,875
-1,510
-2% -$123K 1.46% 36
2016
Q2 		$5.29M Buy
63,385
+2,465
+4% +$219K 1.62% 29
2016
Q1 		$5.6M Sell
60,920
-85
-0.1% -$7.67K 1.8% 22
2015
Q4 		$6.17M Buy
61,005
+2,661
+5% +$277K 1.96% 17
2015
Q3 		$5.73M Sell
58,344
-310
-0.5% -$34.4K 1.71% 20
2015
Q2 		$6.87M Sell
58,654
-3,635
-6% -$397K 1.72% 11
2015
Q1 		$6.11M Buy
62,289
+5,139
+9% +$522K 1.44% 27
2014
Q4 		$5.39M Buy
57,150
+1,040
+2% +$108K 1.41% 35
2014
Q3 		$5.97M Buy
56,110
+1,000
+2% +$97.9K 1.61% 28
2014
Q2 		$4.57M Buy
55,110
+34,640
+169% +$2.7M 1.21% 43
2014
Q1 		$1.45M Buy
20,470
+14,631
+251% +$1.15M 0.42% 65
2013
Q4 		$439K Buy
+5,839
New +$407K 0.13% 78

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Bridgecreek Investment Management's GILD Position: Q1 2017 in Review

Bridgecreek Investment Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 66,855 shares — an estimated $4.79M sold.

Bridgecreek Investment Management first reported a position in GILD in Q4 2013 and held it in 13 quarters. The position peaked at $6.87M in Q2 2015. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Bridgecreek Investment Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Bridgecreek Investment Management sold 66,855 Gilead Sciences shares in Q1 2017, an estimated $4.79M.
  • Bridgecreek Investment Management first reported a position in Gilead Sciences in Q4 2013 and held it in 13 quarters.
  • Bridgecreek Investment Management's Gilead Sciences position peaked at $6.87M in Q2 2015.
  • 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Bridgecreek Investment Management's 13F filing for Q1 2017, filed 2 May 2017.